» Articles » PMID: 37022975

Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in Scotland

Overview
Specialty Endocrinology
Date 2023 Apr 6
PMID 37022975
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Previous studies, including our own, have demonstrated a highly variable incidence of primary hyperparathyroidism (PHPT) from year to year.

Objective: We planned to provide a current estimate of the incidence and prevalence of PHPT in a community-based study.

Methods: A population-based retrospective follow-up study was conducted in Tayside (Scotland) from 2007 to 2018. Record-linkage technology (demography, biochemistry, prescribing, hospital admissions, radiology, and mortality data) was used to identify all patients. Cases of PHPT were defined as those with at least 2 raised serum corrected calcium concentration CCA (> 2.55 mmol/L) and/or hospital admissions with PHPT diagnoses and/or surgery records with parathyroidectomy during the follow-up period. The number of prevalent and incident cases of PHPT per calendar year by age and sex were estimated.

Results: A total of 2118 people (72.3% female, mean age 65 years) were identified with an incident case of PHPT. The overall prevalence of PHPT over the 12 years of the study was 0.84% (95% CI, 0.68%-1.02%), steadily increasing from 0.71% in 2007 to 1.02% in 2018. From 2008, the incidence of PHPT was relatively stable from 4 to 6 cases per 10 000 person-years, declining from 11.5 per 10 000 person-years in 2007. The incidence varied from 0.59 per 10 000 person-years (95% CI, 0.40%-0.77%) for those aged 20 to 29 years, to 12.4 per 10 000 person-years (95% CI, 11.2%-13.3%) in those aged 70 to 79 years. Incidence of PHPT was 2.5 times higher in women than in men.

Conclusion: This study is the first showing a relatively steady annual incidence of PHPT at 4 to 6 per 10 000 person-years. This population-based study reports a PHPT prevalence of 0.84%.

Citing Articles

Assessing and Managing Primary Hyperparathyroidism and Fracture Risk in England: A Survey of Medical Professionals.

Song K, Vijjhalwar R, Aye M, Comninos A, Schini M, Abbas A J Endocr Soc. 2025; 9(2):bvae225.

PMID: 39876875 PMC: 11772554. DOI: 10.1210/jendso/bvae225.


A giant parathyroid cyst causing primary hyperparathyroidism in a pregnant woman: Case report and literature review.

Paz-Ibarra J, Concepcion-Zavaleta M, Coronado-Arroyo J, Quiroz-Aldave J, Pino-Godoy P, Diaz-Lazo H Obstet Med. 2024; :1753495X241249201.

PMID: 39553190 PMC: 11563524. DOI: 10.1177/1753495X241249201.


Outcome of Primary Hyperparathyroidism: Retrospective Tertiary Center Experience From Basrah, Iraq.

Abdul Khaleq S, Nwayyir H, Mansour A Cureus. 2024; 16(7):e65901.

PMID: 39219874 PMC: 11364918. DOI: 10.7759/cureus.65901.


Secular trends in the incidence and treatment patterns of primary hyperparathyroidism in Korea: a nationwide cohort study.

Kim K, Baek S, Yu M, Shin S, Cho S, Rhee Y JBMR Plus. 2024; 8(7):ziae065.

PMID: 38868595 PMC: 11166891. DOI: 10.1093/jbmrpl/ziae065.


Prevalence of Musculoskeletal and Metabolic Disorders in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.

Herreros-Carretero A, Berlanga-Macias C, Martinez-Vizcaino V, Torres-Costoso A, Pascual-Morena C, Hernandez-Castillejo L Transpl Int. 2024; 37():12312.

PMID: 38720821 PMC: 11076774. DOI: 10.3389/ti.2024.12312.


References
1.
Dershem R, Gorvin C, Metpally R, Krishnamurthy S, Smelser D, Hannan F . Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population. Am J Hum Genet. 2020; 106(6):734-747. PMC: 7273533. DOI: 10.1016/j.ajhg.2020.04.006. View

2.
Darba J, Marsa A . Epidemiology and management of parathyroid gland disorders in Spain over 15 years: A retrospective multicentre analysis. PLoS One. 2020; 15(3):e0230130. PMC: 7064228. DOI: 10.1371/journal.pone.0230130. View

3.
Abood A, Vestergaard P . Increasing incidence of primary hyperparathyroidism in Denmark. Dan Med J. 2013; 60(2):A4567. View

4.
Beysel S, Caliskan M, Kizilgul M, Apaydin M, Kan S, Ozbek M . Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism. BMC Cardiovasc Disord. 2019; 19(1):106. PMC: 6505186. DOI: 10.1186/s12872-019-1093-4. View

5.
Wermers R, Khosla S, Atkinson E, Achenbach S, Oberg A, Grant C . Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2005; 21(1):171-7. DOI: 10.1359/JBMR.050910. View